168 related articles for article (PubMed ID: 27736728)
1. Differential expression and response to arsenic stress of MRPs and ASAN1 determine sensitivity of classical multidrug-resistant leukemia cells to arsenic trioxide.
Chen J; Cheng J; Yi J; Xie B; Lin L; Liu Z; Zhao H; Wang B; Ai Z; Yang Y; Wei H
Leuk Res; 2016 Nov; 50():116-122. PubMed ID: 27736728
[TBL] [Abstract][Full Text] [Related]
2. [Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity].
Wei HL; Yao XJ; Li YN; Wang P; Zhao HS; Bai DC; Peng X; Ma LF
Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):28-31. PubMed ID: 12679007
[TBL] [Abstract][Full Text] [Related]
3. Establishment of an arsenic trioxide-resistant human leukemia cell line that shows multidrug resistance.
Seo T; Urasaki Y; Ueda T
Int J Hematol; 2007 Jan; 85(1):26-31. PubMed ID: 17261498
[TBL] [Abstract][Full Text] [Related]
4. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):188-91. PubMed ID: 18756933
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.
Seo T; Urasaki Y; Takemura H; Ueda T
Anticancer Res; 2005; 25(2A):991-8. PubMed ID: 15868938
[TBL] [Abstract][Full Text] [Related]
6. Reversal effect of arsenic sensitivity in human leukemia cell line K562 and K562/ADM using realgar transforming solution.
Wang X; Zhang X; Xu Z; Wang Z; Yue X; Li H
Biol Pharm Bull; 2013; 36(4):641-8. PubMed ID: 23358330
[TBL] [Abstract][Full Text] [Related]
7. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
8. [The effect of arsenic trioxide (As2O3) combined with BSO on K562/ADM cell and its mechanisms].
Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):438-43. PubMed ID: 18072624
[TBL] [Abstract][Full Text] [Related]
9. Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance.
Lehmann S; Bengtzen S; Paul A; Christensson B; Paul C
Eur J Haematol; 2001 Jun; 66(6):357-64. PubMed ID: 11488934
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum stress contributes to arsenic trioxide-induced apoptosis in drug-sensitive and -resistant leukemia cells.
Chen J; Wei H; Xie B; Wang B; Cheng J; Cheng J
Leuk Res; 2012 Dec; 36(12):1526-35. PubMed ID: 22959511
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide inhibits p-glycoprotein expression in multidrug-resistant human leukemia cells that overexpress the MDR1 gene.
Wei H; Su H; Bai D; Zhao H; Ge J; Wang B; Yao X; Ma L
Chin Med J (Engl); 2003 Nov; 116(11):1644-8. PubMed ID: 14642128
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide reduces drug resistance to adriamycin in leukemic K562/A02 cells via multiple mechanisms.
Zhao D; Jiang Y; Dong X; Liu Z; Qu B; Zhang Y; Ma N; Han Q
Biomed Pharmacother; 2011 Aug; 65(5):354-8. PubMed ID: 21775093
[TBL] [Abstract][Full Text] [Related]
13. Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide.
Vernhet L; Allain N; Payen L; Anger JP; Guillouzo A; Fardel O
Biochem Pharmacol; 2001 Jun; 61(11):1387-91. PubMed ID: 11331074
[TBL] [Abstract][Full Text] [Related]
14. [Effects of arsenic trioxide on expressions of vascular endothelial growth factor and P-glycoprotein in multidrug resistant leukemia cell line K562/A02].
Liang H; Zhang Y; Zhang JD; Gu J; Ma L; Wang XL; Shen WG
Zhong Xi Yi Jie He Xue Bao; 2007 Nov; 5(6):647-50. PubMed ID: 17997939
[TBL] [Abstract][Full Text] [Related]
15. [In vitro effect of bortezomib alone or in combination with harringtonine or arsenic trioxide on proliferation and apoptosis of multidrug resistant leukemia cells].
Cai YX; Meng FY; Sun QX; Fu YB; Li L
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):737-40. PubMed ID: 19176009
[TBL] [Abstract][Full Text] [Related]
16. Dose- and time-dependent response of human leukemia (HL-60) cells to arsenic trioxide treatment.
Yedjou CG; Moore P; Tchounwou PB
Int J Environ Res Public Health; 2006 Jun; 3(2):136-40. PubMed ID: 16823087
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 antisense oligodeoxynucleotide increases the sensitivity of leukemic cells to arsenic trioxide.
Zhang Y; Shen WL
Cell Biol Int; 2003; 27(12):953-8. PubMed ID: 14642526
[TBL] [Abstract][Full Text] [Related]
18. Factors determining sensitivity and resistance of tumor cells to arsenic trioxide.
Sertel S; Tome M; Briehl MM; Bauer J; Hock K; Plinkert PK; Efferth T
PLoS One; 2012; 7(5):e35584. PubMed ID: 22590507
[TBL] [Abstract][Full Text] [Related]
19. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide overcomes apoptosis inhibition in K562/ADM cells by regulating vital components in apoptotic pathway.
Wang DH; Wei HL; Zhao HS; Hao CY; Min ZH; Liu JM
Pharmacol Res; 2005 Nov; 52(5):376-85. PubMed ID: 15979894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
